Vind jouw adviseur


​IMAP Brazil (Brasilpar)​ advised Zoetis on sale of pharmaceutical plant to União Química

​IMAP Brazil (Brasilpar)​ is pleased to announce that Zoetis, the largest animal health company worldwide, sold its 144,000 m2 pharmaceutical plant in Guarulhos, São Paulo, to Brazilian pharmaceutical company União Química. The transaction also involved a manufacturing and supply agreement between the parties, according to which União Química will be responsible for the manufacturing of Zoetis’ products.

 

​Zoetis (NYSE: ZTS) – Global leader in animal health, present in more than 100 countries, with approximately 9 thousand employees and revenues of US$ 4.9 billion in 2016. The Brazilian market is the main international operation of Zoetis, representing 5% of its total revenues.

 

União Química – Company with more than 80 years of tradition in the Brazilian market, among the ten largest Brazilian pharmaceutical companies and leader in the manufacturing of pharmaceutical products for third parties.

Contact
CONNECT WITH AN ADVISOR.
Middle-market M&A is a world of opportunity, and with that comes a sea of options and moving parts. Your advisor is the compass. Contact us for a no-commitment consultation with an M&A specialist, who’ll listen carefully to your concerns and give an honest, unbiased assessment on the best way forward.
Our business is your business growth
VRAGEN? 

NEEM CONTACT MET ONS Op 

CONTACT FORMULIER 

Bedankt voor je interesse in IMAP. Gebruik onderstaande formulier om ons meer te vertellen over je huidige situatie, dan zorgen wij ervoor dat de juiste M&A expert zo snel mogelijk contact met je opneemt.